Log in

Start Your Membership Now

In January of 2023, the federal government changed the rules for prescribing buprenorphine.;The new rules increased the cap on the number of consumers using buprenorphine that an individual prescribing clinician could have in their practice and eliminated some training requirements (see;Feds To Ease Regulations Affecting Access To Opioid Addiction Treatment). As a result, any clinician with a current DEA registration that includes Schedule III authority can prescribe buprenorphine for opioid use disorder (OUD) and the maximum number of consumers with substance use disorder (SUD) who can be treated at the same time has increased to 275 . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
Log In
If you are already a member, log in to your account to access this resource and more.

Become A Free Member
You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Treatment Innovation & Treatment Technology